Skip to main content
. 2020 Dec 10;11:2150132720981297. doi: 10.1177/2150132720981297

Table 2.

Univariate and Multivariable Logistic Regression Analyses of Variables Associated with SARS-CoV-2 Test Positivity.

Odds of testing positive uOR (95% CI) P-value Odds of testing positive aORa (95% CI) P-value
Demographics
Age group
16-44 Reference Reference
45-64 1.33 (1.00-1.76) .050 1.75 (1.25-2.44) .001
≥65 1.37 (0.86-2.21) .189 2.78 (1.49-5.16) .001
Sex
Female Reference Reference
Male 1.70 (1.30-2.22) .0001 1.60 (1.19-2.16) .002
Vital Signs
Pulse Oximetry
> 97 % Reference Reference
≤ 97 % 1.53 (1.15-2.03) .004 1.39 (1.00-1.92) .048
Temperature
≤ 98.9° F Reference Reference
≥ 99.0° F 2.92 (2.20-3.88) <.0001 3.06 (2.23-4.20) <.0001
Pulse
≥ 100 Reference Reference
< 100 0.79 (0.55-1.13) .197 0.90 (0.60-1.36) .625
Respiratory Rate
< 17 Reference Reference
≥ 17 1.14 (0.87-1.49) .352 0.99 (0.73 - 1.32) .926
Systolic Blood Pressure
> 120 Reference Reference
≤ 120 1.24 (0.95-1.63) .116 1.64 (1.20-2.24) .002
COMORBIDITIES b
Heart Disease c
Yes 0.64 (0.38-1.06) .083 0.56 (0.31-1.02) .058
Diabetes mellitus d
No Reference Reference
Yes 0.86 (0.51-1.45) .578 0.88 (0.47-1.62) .676
Chronic Lung Disease e
No Reference Reference
Yes 0.57 (0.33 - 0.96) .036 0.55 (0.30-1.02) .057
Asthma f
No Reference Reference
Yes 0.64 (0.41-0.98) .040 0.91 (0.55-1.48) .698
RISK ASSESSMENT QUESTIONNAIRE g
Q1. High-risk Medical Issues
No Reference Reference
Yes 0.74 (0.55-0.99) .040 0.81 (0.56-1.18) .267
Q2. Recent High-risk Travel
No Reference Reference
Yes 1.22 (0.67-2.22) .519 1.34 (0.70-2.56) .374
Q3. COVID Close Contact
No Reference Reference
Yes 1.28 (0.98-1.67) .074 1.56 (1.15-2.10) .004
Q4. COVID at Large Gathering
No Reference Reference
Yes 1.97 (1.19-3.26) .008 1.92 (1.10-3.34) .022
Q5. Decrease in Taste/Smell
No Reference Reference
Yes 2.70 (1.97-3.71) <.0001 2.83 (2.01-3.99) <.0001
Risk Stratification
Low risk Reference
High risk 1.15 (0.82-1.63) .415

Abbreviations: uOR, Unadjusted Odds Ratio; aOR, Adjusted Odds Ratio; 95% CI, 95% Confidence Interval.

Bolded text signifies statistically significant P-values (P < .05).

a

Adjusted for all covariates of interest: age, gender, vital signs (pulse oximetry, temperature, pulse, respiratory rate, systolic blood pressure), comorbidities (heart disease, diabetes, chronic lung disease, asthma), and other risk factors (question 1-5).

b

Comorbidities were derived from patient problem list. Low-risk patients who did not report comorbidities in the risk assessment questionnaire may have had comorbidities documented in the problem list.

c

Heart disease ICD-10 codes I20-I25 or I30-I52 in problem list.

d

Diabetes ICD-10 codes E10-E14 in problem list.

e

Chronic lung disease ICD-10 codes J40-J44 or J46-J47 in problem list.

f

Asthma ICD-10 codes J45 in problem list.

g

Full text of questions 1-5 listed in methods.